Carbosilane dendrons with fatty acids at the core as a new potential microbicide against HSV-2/HIV-1 co-infection

被引:18
|
作者
Guerrero-Beltran, C. [1 ,2 ,3 ,4 ]
Cena-Diez, R. [1 ,2 ,3 ]
Sepulveda-Crespo, D. [1 ,2 ,3 ]
De la Mata, J. [5 ,6 ]
Gomez, R. [5 ,6 ]
Leal, M. [7 ]
Munoz-Fernandez, M. A. [1 ,2 ,3 ,6 ]
Jimenez, J. L. [2 ,3 ,4 ,6 ]
机构
[1] Hosp Gen Univ Gregorio Maranon, Lab Inmunobiol Mol, Immunol Sect, Madrid, Spain
[2] Spanish HIV HGM BioBank, Madrid, Spain
[3] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain
[4] Hosp Gen Univ Gregorio Maranon, Plataforma Lab, Inst Invest Sanit Gregorio Maranon, Madrid, Spain
[5] Univ Alcala, Dept Quim Organ & Quim Inorgan, Campus Univ, Madrid, Spain
[6] Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Madrid, Spain
[7] Hosp Univ Virgen Rocio, Inst Biomed Sevilla IBiS, Seville, Spain
关键词
HERPES-SIMPLEX-VIRUS; HIV-1; TRANSMISSION; DENDRIMER; EFFICACY; COMBINATION; PREVENTION; INHIBITORS; MECHANISM; INFECTION; RECEPTOR;
D O I
10.1039/c7nr05859d
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus type 1 (HIV-1) represent the two most frequent sexually transmitted infections (STI) worldwide. Epidemiological studies suggest that HSV-2 increases the risk of HIV-1 acquisition approximately 3-fold mainly due to the clinical and immunological manifestations. In the absence of vaccines against both STI, the development of new preventive strategies has become essential for further studies. We performed the screening of six novel polyanionic carbosilane dendrons to elucidate their potential activity against HSV-2/HIV-1 co-infection and their mechanism of action. These new nanoparticles are carbosilane branched dendrons from first to third generation, with palmitic or hexanoic fatty acids as the core and capped with sulfonate groups, named G1(d)-STE2Hx, G2(d)-STE4Hx, G3(d)-STE8Hx, G1(d)-STE2Pm, G2(d)-STE4Pm and G3(d)-STE8Pm. G3(d)-STE8Hx and G3(d)-STE8Pm carbosilane branched dendrons showed high viability. These dendrons also showed a great broadspectrum antiviral activity, as well as a suitable efficacy against HIV-1 even if the mucosal disruption occurs as a consequence of HSV-2 infection. Our results exert high inhibition against HSV-2 and HIV-1 by blocking the entry of both viruses with the median effective concentration EC50 values in the nanomolar range. Additionally, G3(d)-STE8Hx and G3(d)-STE8Pm retained their anti-HSV-2/HIV-1 activity at different pH values. G3(d)-STE8Hx and G3(d)-STE8Pm dendrons may be potential candidates as dual-acting microbicides against HSV-2/HIV-1 co-infection.
引用
收藏
页码:17263 / 17273
页数:11
相关论文
共 50 条
  • [31] MicroRNAs, Hepatitis C Virus, and HCV/HIV-1 Co-Infection: New Insights in Pathogenesis and Therapy
    Gupta, Archana
    Swaminathan, Gokul
    Martin-Garcia, Julio
    Navas-Martin, Sonia
    VIRUSES-BASEL, 2012, 4 (11): : 2485 - 2513
  • [32] A potential anti-HIV-1 compound, Q308, inhibits HSV-2 infection and replication in vitro and in vivo
    Zhang, Xin
    Li, Axin
    Li, Ting
    Shou, Zeren
    Li, Yibin
    Qiao, Xinman
    Zhou, Ruijing
    Zhong, Xuelin
    Li, Songshan
    Li, Lin
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 162
  • [33] Genital herpes (HSV-2) seroreactivity correlates strongly with prevalent HIV-1 infection in South African blood donations: A pilot study
    Benjamin, R. J.
    Notari, E. P., III
    Fang, C. T.
    Puren, A.
    Schoub, B. D.
    Tobler, L. H.
    Hogrefe, W.
    Heyns, A. D.
    Busch, M. P.
    Crookes, R. L.
    TRANSFUSION, 2007, 47 (03) : 99A - 99A
  • [34] HIV-1 and HIV-2 co-infection is associated with reduced HIV-1 plasma RNA and DNA levels among Senegalese men and women.
    Critchlow, CW
    Hawes, SE
    Kuypers, JM
    Kwok, S
    Kiviat, NB
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 151 (11) : S14 - S14
  • [35] HIV-1/HIV-2 co-infection among voluntary counselling and testing subjects at a regional hospital in Cameroon
    Nsagha, D. S.
    Njunda, A. L.
    Kamga, H. L. F.
    Assob, J. C. N.
    Bongkem, E. A.
    AFRICAN HEALTH SCIENCES, 2012, 12 (03) : 276 - 281
  • [36] HIV-2 inhibits HIV-1 gene expression via two independent mechanisms during cellular co-infection
    Yapo, Vincent
    Majumder, Kinjal
    Tedbury, Philip R.
    Wen, Xin
    Ong, Yee T.
    Johnson, Marc C.
    Sarafianos, Stefan G.
    JOURNAL OF VIROLOGY, 2023, 97 (12)
  • [37] HSV-1/HSV-2 Infection-Related Cancers in Bantu Populations Driving HIV-1 Prevalence in Africa: Tracking the Origin of AIDS at the Onset of the 20th Century
    Le Goaster, Jacqueline
    Bouree, Patrice
    El Sissy, Franck N.
    Bui, Florence Phuong
    Epee, Johanna Pokossy
    Rollin, Paul
    Tangy, Frederic
    Haenni, Anne-Lise
    CASE REPORTS IN ONCOLOGY, 2016, 9 (03): : 815 - 825
  • [38] META-ANALYSIS OF RANDOMIZED TRIALS OF PROPHYLACTIC ACYCLOVIR AND HIV-1 VIRAL LOAD AMONG INDIVIDUALS CO-INFECTED WITH HSV-2
    Ludema, C.
    Cole, S. R.
    Poole, C.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2011, 173 : S267 - S267
  • [39] Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase
    Visalli, Robert J.
    Ziobrowski, Hannah
    Badri, Kameswara R.
    He, Johnny J.
    Zhang, Xiugen
    Arumugam, Sri Ranjini
    Zhao, Hua
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (16) : 3168 - 3171
  • [40] A stochastic co-infection model for HIV-1 and HIV-2 epidemic incorporating drug resistance and dual saturated incidence rates
    Farah, El Mehdi
    Hajri, Youssra
    Assiri, Taghreed A.
    Amine, Saida
    Ahmad, Shabir
    De la Sen, Manuel
    ALEXANDRIA ENGINEERING JOURNAL, 2023, 84 : 24 - 36